Search results for "Prostate Cancer"
Bisphosphonate use low in men on androgen deprivation therapy despite guidelines
Bisphosphonate prescriptions remain low for men on androgen deprivation therapy (ADT), even for those at high risk of subsequent fractures, a study found.
https://immattersacp.org/weekly/archives/2014/12/09/4.htm
9 Dec 2014
Androgen-deprivation therapy associated with increased risk of cardiac mortality in men with cardiovascular problems
Androgen-deprivation therapy (ADT) for prostate cancer was associated with a 5% absolute excess risk of cardiac-specific mortality at 5 years in men with congestive heart failure or prior myocardial infarction, a study found.
https://immattersacp.org/weekly/archives/2014/11/04/6.htm
4 Nov 2014
Large numbers of elderly patients with low life expectancy still receiving unnecessary cancer screens
A substantial proportion of patients with limited life expectancy are receiving prostate, breast, cervical, and colorectal cancer screenings that are unlikely to benefit them, a recent study found.
https://immattersacp.org/weekly/archives/2014/08/26/1.htm
26 Aug 2014
Cancer society recommends prostate cancer specialists team with primary care physicians to coordinate survivorship care
Prostate cancer specialists should ensure a patient's primary care clinician is included as part of the post-treatment clinical follow-up team, a new guideline stated.
https://immattersacp.org/weekly/archives/2014/06/17/1.htm
17 Jun 2014
Maintaining men's health in middle age
Adrenopause, somatopause, andropause... manopause? They all give internists pause when considering men's health as they reach middle age. As men try to maintain optimum health, doctors need to define what exactly that is.
https://immattersacp.org/archives/2014/04/mens-health.htm
1 Apr 2014
No mortality benefit associated with primary androgen deprivation therapy in localized prostate cancer
Primary androgen deprivation therapy (PADT) yielded no mortality benefit compared with no PADT in men with clinically localized prostate cancer, according to a new study.
https://immattersacp.org/weekly/archives/2014/03/25/5.htm
25 Mar 2014
Surgery performs better than radiotherapy for non-metastatic prostate cancer
Surgery was associated with better survival than radiotherapy in men with non-metastatic prostate cancer, according to a large observational study with follow-up as long as 15 years.
https://immattersacp.org/weekly/archives/2014/03/11/5.htm
11 Mar 2014
Radical prostatectomy may offer advantages over watchful waiting
Men with prostate cancer may survive longer with radical prostatectomy than watchful waiting, especially if they are younger than 65 years of age at diagnosis, a study suggested.
https://immattersacp.org/weekly/archives/2014/03/11/4.htm
11 Mar 2014
Look for reasons if patients refuse advice
Refusal can be frustrating for physicians, who likely see their medical advice as contributing toward healing and improving quality of life. But patients reserve the right to make informed decisions about their care, even if these decisions run counter to what's been recommended.
https://immattersacp.org/archives/2014/02/informed-refusal.htm
1 Feb 2014
Docetaxel may prolong prostate cancer survival in patients with metastasis
Docetaxel added to the start of hormone therapy for metastatic prostate cancer may prolong survival compared to patients who received hormone therapy alone, according to early results from a trial.
https://immattersacp.org/weekly/archives/2013/12/17/4.htm
17 Dec 2013